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Evidence has been presented in a companion paper (1) to show that immune 
sera against guinea pig complement can be produced in rabbits by injection of 
guinea pig globulin or sensitized  erythrocyte stromata exposed to guinea pig 
complement (SAC').  Sensitized erythrocytes exposed to complement (EAC') 
are agglutinated by these immune sera after absorption  of the sera with sensi- 
tized erythrocytes; and when mixed with the immune serum conjugated with 
fluorescein they exhibit specific fluorescence on microscopic examination with 
ultraviolet light. These specific immune reactions have been demonstrated to be 
unrelated to immunoconglutinins. 
The purpose of this paper is to describe the role of each of the fixable compo- 
nents of guinea pig complement in the agglutination of EAC' by the immune 
sera prepared against guinea pig complement. Since the fixation of complement 
to sensitized erythrocytes occurs in a series of reaction steps,  it is possible to 
produce individual complexes, each comprising sensitized erythrocytes with one 
or more of the components of complement. The agglutinogenic capacity of each 
of these components in complex with sensitized erythrocytes can then be tested 
in parallel with examination of the hemolytic function of each component. In a 
preceding paper (2) a method was described for producing by ether treatment 
of guinea pig serum a stable complex of sensitized erythrocytes in combination 
with the first component of complement (EAC'I). This permits analysis of the 
immune sera for antibodies  against the first component of complement.  And 
since this EAC'I is highly reactive with the fourth component of complement 
(C'4), an EAC'1,4 can be produced to analyze the immune sera for antibodies 
against the fourth component.  This stepwise procedure  can be continued for 
analysis of other components of complement. 
* This work was supported by research grant H-1803 of the National Heart Institute of the 
National Institutes of Health and by the Helen Hay Whitney Foundation. 
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Materials and  Methods 
The preparation and use of saline, sensitized cells, and complement reagents, the procedure 
for determining the hemolytic reactivity of persensitized cells to complement reagents, and 
the hemagglutination tests have been described elsewhere (1). The immune sera referred to in 
this paper are identical with those that have been described earlier (1). Three preparations of 
rabbit anti-guinea pig serum globulin (sera 23, 40, and 41) and two preparations of rabbit 
anti-SAC  t  (sera 26 and 27)  were used. Anti-SAC  t was obtained by injecting rabbits with a 
mixture of Fretmd's adjuvant and sensitized stromata exposed  to guinea pig complement. 
For control purposes rabbit anti-egg albumin serum was used (serum 29). All immune sera 
were absorbed with non-sensitized and sensitized erythrocytes. 
Sensitization of Erythroeytes.--Erythrocytes  sensitized with 8 amboceptor units (EA) were 
used  throughout this investigation for the agglutination tests.  This corresponded  to  one- 
quarter of the minimal amount of amboceptor that caused agglutination. All cell suspensions 
were adjusted to a  density of 0.5  X  10  ~ cdls/ml. For absorption of  the immune sera cells 
sensitized with 16 units of amboceptor were used. 
Preparation of EA C'I.--A suitable amount of an EA suspension was chilled and mixed with 
an equal volume of a chilled dilution of 1:50 of ether-inactivated complement (CLether). The 
mixture was kept for 30 minutes in ice water. The cells were then washed three times with ice 
cold buffered saline and resuspended in buffered saline (2). The same technique was applied 
when R4 (hydrazine-inactivated complement) was used as source of Ctl. The cells obtained by 
both procedures showed a high reactivity against R1 and none against R4 or chelated comple- 
ment, indicating that an EACtl preparation had been formed. 
Preparation of EACtl,4.--(a)  A  chilled suspension of EACtl was mixed with an equal 
volume of a chilled dilution of 1:40 of heat-inactivated complement (H) and kept for ~  hour 
in ice water. The cells were then washed three times with ice-cold buffered saline and resus- 
pended. These cells showed a  high reactivity to R1 and to R4 and no reactivity to chelated 
complement, indicating that an EACtl,4 preparation had been formed. The incubation in the 
cold is essential. When the mixture is incubated at 37  ° the cells show a high reactivity against 
R4 but their reactivity to R1 is feeble. 
(b) A suspension of EACtl was chilled and mixed with an equal amount of a  chilled 1:10 
dilution of complement that had previously been chelated by adding EDTA in an amount to 
give a concentration in the final mixture of 0.01 g  EDTA. The mixture was kept in ice water 
for 5 minutes. The cells were then washed three times with an ice-cold buffer which had been 
deprived of its bivalent cations by resin passage. Finally the cells were resuspended in normal 
buffered saline. These cells showed a  high reactivity to R4, a  moderate or feeble one to R1, 
and none to chelated complement, indicating that an EACtl, 4 preparation had been formed 
with some loss of the CPl activity. 
Preparation of EACtI,4,~.--(a)  A  suspension of  EAC'I,4  prepared  according to  the 
procedure given in paragraph (a) of the section above, was mixed with an equal volume of an 
endpiece 1: 50 derived from R4 (R4-endpiece). The mixture was kept for 5 minutes at 370 and 
the cells were then washed three times with ice-cold buffered saline, resuspended, and kept in 
an ice-water bath. The preparation of R4-endpiece was carried out as follows: to 4 ml. of guinea 
pig serum 1 ml. of a 0.16 ~  solution of hydrazine was added. The mixture was incubated for 3 
hours at 37  °. The pH was then adjusted to 7.2 by adding 0.2 ~r HCI and the mixture was 
brought up to a final volume of 6 ml. with buffered saline and then chilled. A volume of 45 ml. 
of chilled HC1 1/250 N was then added dropwise and the volume was made up finally to 60 ml. 
by adding ice-cold distilled water. The mixture was kept in ice water for 30 minutes and the 
precipitated euglobulins were  spun down.  The supernatant was brought up  to  isotonicity 
with 10 per cent NaC1 solution and to  a  pH of  7.2 with 0.15 ~t dibasic sodium phosphate. 
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guinea pig serum. This preparation showed no detectable amount of Ct3, since the prolonged 
incubation with hydrazine inactivates most  of  it  and  the  rest  is  precipitated  with  the 
euglobulins. The ct2 titer of R4-endpiece is high, usually between 1600 and 3200 units/inf., 
whereas no trace of Ct4 and of Cq can be detected. When EACtl,4 was incubated with R4- 
endpiece the resulting cells showed a  high reactivity against R1, R4, and chelated comple- 
ment, indicating that Cv2 had been added without any loss of Ctl  or Ct4 activity. No for- 
mation of E* was detectable. 
(b)  An EA suspension was mixed with equal parts of a dilution of 1:20 of an R3, the latter 
having been obtained by the cobra venom method (2). The mixture was incubated for 5 min- 
utes at 37  ° and the cells were washed and resuspended in ice-cold buffered saline. No formation 
of E* could be detected. The cells reacted strongly with R1, R4, and chelated complement, 
again indicating that an EAC tl, 4, 2 preparation had been made. 
(c)  An EA suspension was chilled and mixed with equal amounts of a chilled dilution of 1: 50 
of active complement (Ct). The mixture was kept in the cold for 1 hour and the cells were 
washed with ice-cold buffered saline. The washed cells were kept for 4  hours in ice water. 
Approximately 30 per cent of the cells were lost by the formation of E* and the rest of the 
cells were resuspended in ice-cold buffered saline. The cells showed a strong reactivity with R1, 
R4,  and chelated complement, once again indicating that an EACtl,4,2  preparation had 
resulted. 
Removal of CP  4 from tteat-Inactivated Complement.--EACq was prepared with ether-treated 
complement as indicated above. The absorption of C~4 from heat-inactivated complement (I-I) 
was performed by mixing a sediment of 50 X  109 of packed EACq cells in 10 ml. of a  1:10 
dilution of the heat-inactivated complement (H) for 30 minutes at 37  °. The cells were then 
spun down and the superuatant, designated as Ha (I-I minus Cr4) was used. On testing, this 
preparation showed no detectable Ct4. Its Ct3 titer was in the same range as that of non- 
treated H. As a control H  was treated in the same fashion with EA. No decrease in Ct4 or in 
C t3 was detectable. This control preparation was designated as Ho. 
Decomplementagion of Guinea Pig Serum.--Guinea  pig  serum  was  decomplemented  by 
treating it twice with sensitized stromata as described elsewhere (2). 
Absorption of the Immune Sera with EA Ctl,.~.--Erythrocytes  sensitized with 16 units of 
amboceptor were converted to EAC'I,4 by using the method described in paragraph (b) in 
the section on the preparation of EACrl,4.  The immune sera were absorbed by mixing the 
sediment of 50 X  109 EACh1,4 cells with 20 ml. of a  1:20 dilution of the respective immune 
serum. This suspension was incubated for one-half hour at 37  °  . The cells were then spun down 
and the superuatant was subjected to the same treatment once more. This treatment exhausted 
the agglutinating power of the sera against EACtl, 4. 
Inactivation  of Fixed Ctl  by Citrate.--A  suspension of EACtl  was mixed with an equal 
amount of 0.15 ~  sodium citrate solution and the mixture was kept at 370 for 30 minutes. The 
cells were then washed twice and resuspended in buffered saline. This treatment completely 
destroyed the reactivity of EACrl with R1. Citrate should be used for this procedure rather 
than EDTA because it was observed that prolonged exposure to EDTA in the absence of pro- 
tein causes a slight spontaneous agglutination of the cells. As a control a portion of EACtl was 
exposed under the same conditions to buffered saline instead of citrate. 
EXPERIMENTAL 
Samples of a suspension of EA were exposed in sequence to various complement reagents as 
indicated in Table I. The cells were then washed, resuspended, and subjected to agglutination 
tests with the anti-gulnea pig globulin sera 23, 40, and 41, with the anti-SAC  v sera 26 and 27, 
and with the anti-egg albumin serum 29. The exposure of EA to the complement reagents was 110  ANTIGENIC  PROPERTIES  OF  COMPLEMENT.  II 
carried out at 3  °. All immune sera were tested against each of the cell preparations in twofold 
dilution ranging from 1:20 to 1:5120. The results are summarized in Table I. 
It can be seen that the preparation EAC'I showed no agglutination with the 
immune  sera  regardless  of  whether  hydrazine-inactivated  complement  or 
ether-inactivated complement was used as a  source of fixable C'I. When, how- 
ever, in a  second step EAC'I was exposed to heat-inactivated  complement it 
TABLE I 
Hemolytic Reactivity and Agglutinability  of Cdls Persensitized with Various 
Complement Components 
EA exposed in sequence 
to 
I 
Ist step  I  2nd step 
I 
C'-ether  Saline 
R4  Saline 
C'-ether  H 
R4  H 
F.'  Saline 
;aline  Saline 
Formula  of 
~r.uavarv  u~ 
tlvity 
EAC'I 
EAC'I 
EAC'1,4 
EAC'1,4 
EAC'I,4,2 
EA 
I 
Hemolytic reac-  I Agglutination,  intensity, and endpoint dilution  tivity with C'  reagents*  }  with immune sera 
]/ 
xxx  0  0  0 
xxx  0  0  0 
xxx xxx  0  0 
xxx xxx  0  0 
KXX XXX XXX  0 
0000 
23 
0 
0 
+ 
1:150 
+ 
1:150 
+++ 
1:320 
26 
0 
0 
+ 
1:6t4) 
+ 
1:540! 
+++1 
1:640 i 
0 
27  40  41 
0  0  0 
0  0  0 
+  +  + 
1:640  1:640  1:640 
+  +  i+ 
1:540  1:6401 1:540 
I 
+++ +++i+++ 
1:540  1:540  1:540 
0  Io  I 
* In Tables I to III, the symbols xxx, xx, and x mean complete hemolysis in less than 5, 
15, and 30 minutes respectively, x means incomplete hemolysis after 30 minutes of incuba- 
tion at 37°C. 
was converted into EAC'1,4 and this preparation showed a marked agglutina- 
tion with all immune sera  except the anti-egg albumin  (serum  29).  The cells 
exposed  to active  complement  corresponded  to  the  formula EACq ,4,2  and 
showed an agglutination that appeared far stronger than that obtained by using 
EAC'1,4 cells. Finally the control EA showed no agglutination with any of the 
sera.  The  conclusion  can  be  made,  therefore,  that  fixed  C'1  itself  shows  no 
agglutinogenic  properties.  On  the  other  hand,  fixed  C'4  seems  to  act  as  an 
agglutinogen since the cells are rendered agglutinable simultaneously with the 
fixation of C'4. The question arises as to whether the fixation of this agglutino- 
gen to the cells would parallel  the fixation of C~4 under different experimental 
circumstances. This point was investigated. P.  G.  KLEIN  AND  P.  M.  BU'RKHOLDER  III 
A suspension of EA was exposed in sequence to various complement reagents as indicated 
in Table II. The cell preparations  were tested  for their hemolytic reactivity and for their 
agglutination with serum 40 (anti-guinea  pig globulin), serum 27 (anti-SAC', absorbed with E 
and EA), and serum 29 (anti-egg albumin);  and for each type of serum twofold  serial dilutions 
were made from 1:10 to 1: 5120. Table II summarizes the results. 
TABLE II 
A gglutinabil ity of EA C'  I  and of EA C'1,4 with Anti-Corn ~lement 
EA exposed in sequence to 
Ist step  2nd  step  3rd step 
Formula of 
hemolytic re- 
activity 
C'-ether  Saline  Saline  EAC'I 
C'-ether  Citrate  H  EA 
~'-ether  Saline  H  EAC'I,  4 
H  Saline  Saline  EA 
E'-ether  Ha  Saline  EAC'I 
;'-ether  Ho  Saline  EAC'I,  4 
E'-ether  H  "4-  Saline  EAC'I,  4 
EDTA 
G'-ether  C'  +  Saline  EAC'I,  4 
EDTA 
E'-ether  H  Saline 
+  EDTA 
3aline  Saline  Saline 
EA  0 
EA  0 
IAgglutination, intensity, 
Hemolytic reactivity with  and  endpoint  dilution 
C' reagents  with immune sera 
C' "4-  Saline  40  27  29  RI  R4  EDTA 
t 
xxx  0  I  0  0  0  0  0 
0  0  0 
xxx  xx  0  0  +  +  0 
1:640  1:640 
0  !  0  0  0  0 
xxx  I  0  0  0  0 
xxx  ]  0  0 
x 
x 
0  0  0  0 
! 
r 
0 
! 
0 
xx 
I 
! 
0 
! 
xxx!  0 
I 
[ 
i 
0 
! 
i 
0 
+ 
1:640 
0  + 
1: 320 
0  4-+ 
1:320 
0  0 
0  0 
+ 
1: 320 
+ 
1:160 
++ 
1:320 
0 
It can be seen that the fixation or failure of fixation of C'4 and of the aggluti- 
nogen to sensitized cells occurs in parallel under several well defined circum- 
stances as  follows:  (a)  No  C'4  and no agglutinogen can  be  fixed  when EA 
interacts with heat-inactivated complement. (b) The fixation of C'4 as well as 
the fixation of the agglutinogen requires the presence of hemolytically active 
C'I on the cells. An EAC'I exposed to citrate at 37  ° loses its hemolytic reac- 
tivity to R1  as  well as its capacity to fix C'4 and the agglutinogen. An EA 
exposed to ether-inactivated complement in the presence of EDTA showed no 
lysis with R1  and is unable to fix either C'4 or the agglutinogen. (c)  By ab- 112  ANTIGENIC  PROPERTIES  OF COMPLEMENT.  II 
sorbing heat-inactivated complement with EACtl the capacity of the resulting 
Ha  to  transfer  hemolytically active  CP4  or  the  agglutinogen  onto  EAC'I  is 
exhausted. The titration of Ha for C'4 also shows complete absence of C'4. (d) 
The transfer of both Ct4 and the agglutinogen to EAC"I takes place even in the 
presence of EDTA. Therefore, the transfer of both is independent of calcium 
and magnesium ions. 
The conclusion can be made from this experiment that during the interac- 
tion of EAC'I with heat-inactivated or with chelated complement an agglutino- 
gen indistinguishable from hemolytically active C~4 is transferred to the cells. 
An experiment was undertaken to examine the role of fixed C~2 in the agglutination. The 
cell preparations tested in Table III were exposed to immune sera and to the same immune 
sera that had previously been absorbed with EACP1,4. The non-absorbed sera are designated 
as Nos. 23, 26, 27, 40, and 41, whereas the absorbed sera are designated as Nos. 23a, 26a, 27a, 
40a, and 41a. The absorbed sera were tested in twofold dilutions between 1:20 and 1:5120 
against each cell preparation. The non-absorbed sera were used in a dilution of 1:40. 
The results summarized in Table III show that it is possible to remove the 
agglutinins  directed  against  fixed  C~4  by  absorbing  the  immune  sera  with 
EAC~1,4. Accordingly EACh1,4 is agglutinated only by the non-absorbed sera 
whereas it fails to be agglutinated by the absorbed sera. An EAC'1,4,2, pro- 
duced by attaching C'I, C'4, and C'2 to EA in sequence, as described under (a) 
in the section on preparation of EACP1,4,2,  shows no agglutination with the 
absorbed sera, whereas it is markedly agglutinated by the non-absorbed sera. 
The same behavior is shownby an EAC'1,4,2 preparation obtained by exposing 
EA to complement inactivated by cobra venom. Therefore the fixation of C'2 
alone to the complex EAC'1,4 does not transfer any additional agglutinogen 
distinct  from C'4. When, however, EA interacts with active complement the 
resulting  compound  (EAC'),  corresponding  to  the  hemolytic  formula 
EAC'1,4,2, appears to have acquired an additional agglutinogen apart from 
C'4, since it shows a  strong agglutination with the absorbed sera. It must be 
noted that during the inactivation of EA with active complement some of the 
cells are converted to E* which means that a limited reaction had taken place 
between the resulting EAC'1,4,2 and C'3. It is conceivable, then, that during 
the interaction of EA with active complement traces of C'3 are fixed even to 
those cells that are not converted to E*, and that this minute amount of fixed 
C'3 might act as an agglutinogen.  To examine this  possibility the following 
experiment was performed. 
An EAC/1,4,2 was obtained by incubating EA with complement that had been treated 
with cobra venom. Samples of the EAC~I,4,2 suspensions  were mixed with equal parts  of 
(a)  decomplemented guinea pig serum 1:300,  (b) hydrazine-treated  guinea pig serum 1:60, 
and (c) active guinea pig serum 1:600. The incubations were performed at 37 ° for i0 minutes 
and resulted in incomplete ]ysis of the suspensions in all three instances. The remaining cells 
were then spun down and washed three times with ice-cold saline. The cells were stored in ice P.  G.  KLEIN  AND  P.  M.  BURKHOLDER  11,3 
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water for 4 hours. The loss of cells by lysis was estimated and the remaining cells adjusted to 
the original concentration. They were then examined for agglutination with the immune sera 
(Nos. 26, 27, 40, and 41) and with the absorbed immune  sera that were deprivedof their agglu- 
tinins against Ct4 (Nos. 26a, 27a, 40a, and 41a). 
The results summarized in Table IV show that the EAC'1,4,2 cells, obtained 
by interacting EA with R3, were agglutinated by immune sera but not by the 
absorbed immune sera. The exposure of the EAC'I ,4,2 cells to active comple- 
ment caused 10 per cent lysis, indicating that a limited reaction with C'3 had 
taken place at the same time that the remaining cells were rendered agglutinable 
by the absorbed sera. When, however, the EACq ,4,2 cells were treated with 
TABLE IV 
Agglutination of a Persensitized,  Partially Lysed EA 
EA exposed in sequence to 
1st step 
R3 (cobra venom) 
R3 (cobra venom) 
R3 (cobra venom) 
R3 (cobra venom) 
Saline 
2nd step 
Saline 
Decomple- 
mented guinea 
pig serum 
R4 
C' 
Saline 
] the 2nd 
I  step 
I per ce~ 
<3 
5O 
30 
10 
<3 
I  Agglutination with non-  t  .AggrlUt!~pti°n with 
absorbed immune sera 1:80/a°s°  oea IreS0 une sera 
/ 
26  27  40  4t  29  26  a  27a  40a  41a 
++ 
+ 
+  + 
+++ 
0  0 
I 
++ 
+ 
++++  0 
++++  0 
++  ++  0 
++  ++  0 
0  0  0 
0  0 
0  0 
0  0 
+  + 
0  0 
0  0 
0  0 
0  0 
+  0 
0  0 
R4 or with decomplemented guinea pig serum the lysis proved to be greater 
than when active complement was used; and yet in these cases the cells were 
not  rendered  agglutinable  with  the  absorbed  sera.  Therefore,  among  three 
reagents  that  are  able  to partially lyse EAC'I ,4,2  only active complement 
transmits an additional agglutinogen to the cells, whereas the other two reagents 
(R4 and decomplemented complement) fail to do so. This experiment indicates 
that the transfer of an additional agglutinogen to EAC'1,4,2  shows no direct 
relation to the degree of hemolysis; i.e.,  the extent to which  the EAC'1,4,2 
cells have reacted with C'3 to form E*. On this basis the possibility already 
considered that a sublytic amount of fixed C'3 is identical with the additionally 
transferred agglutinogen is unlikely. 
Attempts were made to further characterize the fixability of the additional 
agglutinogen to EAC'1,4,2 using different sources of complement reagents. 
An EACt1,4,2 suspension was prepared with complement inactivated by cobra venom as 
outlined above.  Chilled specimens  of this  EACtl,4,2  suspension were mixed with equal 
volumes of several complement reagents indicated in Table V. The mixtures were kept in ice P.  G.  KLEIN  AND  P.  M.  BURKHOLDER  115 
water for 1 hour, centrifuged, and then the cells washed with ice-cold saline. The cells exposed 
to chelated complement were washed twice with citrated saline and once with buffered saline. 
The cells were then exposed to non-absorbed immune sera and to absorbed immune sera that 
were deprived of their anti-CP4 agglutinins. 
Table V  shows  that  an additional  agglutinogen different from C'4 can be 
transferred to EAC'1,4,2 by exposing the cell preparation to active comple- 
ment or to heat-inactivated complement. This transfer takes place even in the 
presence of EDTA,  and is  thus independent of bivalent cations.  It is note- 
worthy that the transfer of this agglutinogen from heat-inactivated complement 
to EAC'1,4,2 takes place even when the former has been deprived of its C'4 
(Ha) by previous exposure to EAC'I.  This finding represents additional evi- 
TABLE  V 
Rote of Various Complement Reagents az Donors of the Additional Agglutinogen 
Agglutination with non-absorbed immune  Agglutination with absorbed immune 
EA exposed first to 1~  sera 1:80  sera 1:80 
cobra venom) and subse- 
quently to 
26  41  41a 
$aline 
=' 1:50 
:' 1  : 50 +  EDTA 
FI 1:20 
Ha 1:20 
R4 1:10 
R3 (zymosan) 1:30 
+ 
+++ 
+++ 
++ 
++ 
+ 
++ 
27  40 
+  + 
+++  +++ 
+++  +++ 
+++  +++ 
+++  +++ 
+  + 
++  +++ 
+ 
+++ 
+++ 
+++ 
+++ 
+ 
++ 
29  2~ 
o  o 
o  + 
o  ++ 
o  + 
o  + 
o  o 
o  o 
27a  46 
o  o 
++  +++ 
+++  +++ 
+++  ++ 
+++  ++ 
0  0 
0  0 
0 
+++ 
+++ 
+ 
++ 
0 
0 
dence for the conclusion that  C'4 is distinct from the additionally transferred 
agglutinogen. R3 prepared by zymosan as well as R4 prepared by hydrazine 
both failed to transfer the additional agglutinogen. 
DISCUSSION 
The experiments reported in this paper show that a clear and very close rela- 
tionship exists between the fixation of hemolytically active C'4 and the fixation 
of an agglutinogen to sensitized sheep cells from guinea pig serum. Indeed, it 
appears that C'4 is truly fixed and acts as an agglutinogen. Neither the fixation 
of C'I nor that of C'2 appears to contribute to the agglutinability of the cells 
with respect to "anti-complement." Furthermore, an additional  agglutinogen 
distinct from C'4 is acquired during the interaction of EA and active comple- 
ment. The identity of this additional agghitinogen with hemolytically active 
C'3 is unlikely. 
There are several alternatives to explain the fact that neither C'I nor C'2 is 
involved in the agglutination. First, one must consider the possibility that both 116  ANTIGENIC  PROPERTIES  O]~  COMPLEMENT.  H 
Cq and  Ct2 interact  with the cell without being truly "fixed"; i.e.,  without 
the attachment of new material to the cell. As far as Ct2 is concerned this hy- 
pothesis is in accordance with the theory suggested by Lepow and coworkers 
(3). According  to Lepow human Ct4 and CP2 may be inactivated by fixed Cq 
without being attached to the antigen-antibody aggregate.  However, the failure 
of Ctl  to act as an agglutinogen cannot be explained  by assuming that  this 
component interacts  with  EA without  being truly fixed,  since  according  to 
Heidelberger and coworkers (4) the bulk of fixed complement material belongs 
to the component Cq. If one accepts this latter view, only two explanations can 
be offered for our findings, namely that C'I though antigenic (5) isnot aggluti- 
nogenic, or that it has no antigenic properties at all. If one took into considera- 
tion only Cq and C~2, the data presented here would appear to be consistent 
with the hypothesis of Lepow referred to above. But with respect to the role of 
fixed C~4 in agglutination with "anti-complement," our observations'cannot be 
easily  reconciled  with  Lepow's hypothesis,  because  they  indicate  that  the 
interaction of the cells with hemolytic Ct4 is invariably accompanied by the 
attachment of an agglutinogen.  Since this agglutinogen exhibits all the traits 
characteristic of C~4 and since no property can be found to distinguish it from 
C~4, the assumption seems justified that this agglutinogen and CP4 are identical. 
This would then imply that the interaction between EACq and Ct4 leads to a 
true fixation of the latter. 
On the basis of the findings presented in this report it is impossible to deter- 
mine whether C'3 is antigenic or not. The agglutination technique with persen- 
sitized cells is not suitable for an investigation of this problem since hemolysis 
prevents experiments with more than sublytic amounts of fixed CP3. The addi- 
tional agglutinogen that we have found to be distinct from C'4 exhibits proper- 
ties like those characteristic for C'3: it can be fixed from heat-inactivated com- 
plement but not from guinea pig serum inactivated by either zymosan or cobra 
venom; it can be attached only to EACq ,4,2 and not to EACq ,4; its fixation 
is independent of bivalent cations.  On the other hand,  it is unlike Ct3 in that 
it is not fixable from R4; moreover, it is possible to expose EACq ,4,2  cells to 
an amount of C~3 from decomplemented guinea pig serum and from R4 that 
produces partial lysis without attaching the agglutinogen to the surviving cells. 
Further studies are required to establish whether this additional agglutinogen 
bears any relation at all  to the process of immune hemolysis. The possibility 
must be considered  that the complement components which are demonstrable 
in hemolysis may represent only a part of the fixable complement material. 
S~tRY 
Sheep erythrocytes sensitized  with amboceptor and persensitized thereafter 
with guinea pig complement are agglutinated by rabbit anti-guir~ea pig globulin 
and by immune sera obtained by injection of rabbits with fixed  complement. P.  G.  KLEIN AND P.  M.  BURKHOLDER  117 
In  this  agglutination  neither  C'I  nor  C'2  takes part.  Fixed  C'4 acts  as  an 
agglutinogen.  An  additional  agglutinogen,  distinct  from  CI4,  was  found  on 
persensitized  cells.  This  additional  agglutinogen  appears  to be distinct  from 
hemolytically active C'3. 
BIBLIOGRAPHY 
1.  Klein, P. G., and Burkholder, P. M., Studies on the antigenic properties of comple- 
ment. I. Demonstration of agglutinating antibodies against guinea pig comple- 
ment fixed on sensitized  sheep erythrocytes, J. Exp. Med., 1960, 111, 93. 
2.  Klein, P. G., Studies on immune hemolysis: Preparation of a stable and highly reac- 
tive complex of sensitized  erythrocytes and the first component of complement 
(EACtl); inactivation of cell-fixed Cq  by some complement reagents, J. Exp. 
Med., 1950, 111, 77. 
3.  Lepow, I. H., Wurz, L., Ratnoff, O. D., and Pillemer, L., Studies on the mechanism 
of  inactivation  of human  complement by plasmin  and  by antigen-antibody 
aggregates. I. The requirement for a factor resembling Cq and the role of Ca  ++, 
J. Immunol., 1954, 73, 146. 
4.  Heidelberger, M., Rocha e Sylva, M., and Mayer, M. M., Quantitative chemical 
studies on complement or alexine.  III. Uptake of complement nitrogen under 
varying experimental conditions,  J. Exp. Med., 1941, 73,695. 
5.  Ellis,  H.  A.,  and  Gell,  P.  G. H.,  Immunological estimation  of a  component of 
complement, Nature, 1958, 181, 1667. 